[1]
2024. Dupilumab Improves Disease Control and Patient-Reported Outcomes in Adults with Atopic Dermatitis in Clinical Practice: Subgroup Analysis of Black/African American Population from RELIEVE-AD. SKIN The Journal of Cutaneous Medicine. 8, 1 (Jan. 2024), s327. DOI:https://doi.org/10.25251/skin.8.supp.327.